152 related articles for article (PubMed ID: 15468724)
1. [Clinical and immunological characteristics of primary and secondary antiphospholipid syndrome].
Sulut'ian AE; Chapaeva NN; Shirinskiĭ VS; Kozhevnikov VS; Kozlov VA
Klin Med (Mosk); 2004; 82(8):39-43. PubMed ID: 15468724
[TBL] [Abstract][Full Text] [Related]
2. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome?
Weber M; Hayem G; De Bandt M; Seifert B; Palazzo E; Roux S; Kahn MF; Meyer O
J Rheumatol; 1999 Oct; 26(10):2131-6. PubMed ID: 10529128
[TBL] [Abstract][Full Text] [Related]
3. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
[TBL] [Abstract][Full Text] [Related]
4. [Soluble CD40 ligand in systemic lupus erythematosus and antiphospholipid syndrome].
Aleksandrova EN; Novikov AA; Popkova TV; Reshetniak TM; Novikova DS; Kliukvina NG; Il'ina AE; Mach ES; Volkov AV; Nasonov EL
Ter Arkh; 2006; 78(6):35-9. PubMed ID: 16881361
[TBL] [Abstract][Full Text] [Related]
5. [Catastrophic antiphospholipid syndrome: diagnosis and treatment].
Reshetniak TM; Aleksandrova EN; Shtivel'band IB; Radenska-Lopovok SG
Ter Arkh; 2005; 77(5):41-7. PubMed ID: 15989002
[TBL] [Abstract][Full Text] [Related]
6. High-sensitivity C-reactive protein: discriminator between patients with primary and secondary antiphospholipid syndrome.
Bećarević M; Majkić-Singh N
Clin Biochem; 2008 Dec; 41(18):1449-53. PubMed ID: 18801352
[TBL] [Abstract][Full Text] [Related]
7. Primary antiphospholipid syndrome: a distinct entity?
Mackworth-Young C
Autoimmun Rev; 2006 Jan; 5(1):70-5. PubMed ID: 16338214
[TBL] [Abstract][Full Text] [Related]
8. [Soluble adhesion molecules in antiphospholipid syndrome associated with systemic lupus erythematosus and in primary antiphospholipid syndrome].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina NG; Reshetniak DV; Samsonov MIu; Nasonov EL
Ter Arkh; 2002; 74(5):23-7. PubMed ID: 12087900
[TBL] [Abstract][Full Text] [Related]
9. Primary, Secondary, Catastrophic Antiphospholipid Syndrome: is there a difference?
Harris EN; Pierangeli SS
Thromb Res; 2004; 114(5-6):357-61. PubMed ID: 15507265
[TBL] [Abstract][Full Text] [Related]
10. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
11. Ocular manifestations in antiphospholipid syndrome.
Suvajac G; Stojanovich L; Milenkovich S
Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
[TBL] [Abstract][Full Text] [Related]
12. [Osteonecroses in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Lisitsyna TA; Nasonov EL
Klin Med (Mosk); 2004; 82(6):46-51. PubMed ID: 15344691
[TBL] [Abstract][Full Text] [Related]
13. Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome.
Krause I; Lev S; Fraser A; Blank M; Lorber M; Stojanovich L; Rovensky J; Chapman J; Shoenfeld Y
Ann Rheum Dis; 2005 Oct; 64(10):1490-3. PubMed ID: 15778242
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
Tektonidou MG; Sotsiou F; Moutsopoulos HM
J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid syndrome--the description of two cases].
Podrazilová L; Peterová V; Olejárová M; Seidl Z; Dostál C
Vnitr Lek; 2006 Jan; 52(1):89-94. PubMed ID: 16526206
[TBL] [Abstract][Full Text] [Related]
16. [Antiphospholipid syndrome (APS) primary (PAPS) and secondary (SAPS)].
Chwalińska-Sadowska H; Meissner M; Wudarski M; Zabek J; Wojciechowska B
Pol Arch Med Wewn; 2006 May; 115(5):401-6. PubMed ID: 17195351
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary dysfunction in systemic lupus erythematosus and anti-phospholipid syndrome patients.
Paran D; Fireman E; Levartovsky D; Elkayam O; Kaufman I; Litinsky I; Caspi D; Koifman B; Keren G; Schwarz Y
Scand J Rheumatol; 2007; 36(4):285-90. PubMed ID: 17763206
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
19. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
Harris EN; Pierangeli SS
Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Avcin T; Silverman ED
Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
